Phase II trial of eribulin in patients with metastatic hormone refractory prostate cancer: A trial of the ECOG-ACRIN Cancer Research Group (E5805)

Mark N. Stein, Yu Hui Chen, Michael A. Carducci, Gary R. Hudes, Pauline M. Lerma, Winston W. Tan, Robert Dalune, Kendrith M. Rowland, Timothy M. Kuzel, Robert S. DiPaola

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Phase II trial of eribulin in patients with metastatic hormone refractory prostate cancer: A trial of the ECOG-ACRIN Cancer Research Group (E5805)'. Together they form a unique fingerprint.

Medicine & Life Sciences